MacroGenics | Der Umsatz

Created with Highcharts 10.1.0Chart context menu976K18.6M38.9M59.2M79.5M99.9M117M
2022Q32023Q32024Q3


Sales Veränderung Datum
AbbVie USD 15.1B 642M 2024-12
Amgen USD 9.09B 583M 2024-12
AstraZeneca USD 14.89B 1.32B 2024-12
Biogen USD 2.45B 11.1M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Daiichi Sankyo JPY 484.84B 38.29B 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
Genmab DKK 64.41B 58.87B 2024-12
Geron USD 47.54M 19.27M 2024-12
Gilead Sciences USD 7.57B 24M 2024-12
J&J USD 22.52B 49M 2024-12
MacroGenics USD 19.35M 91.35M 2024-12
Merck USD 15.62B 1.03B 2024-12
Pfizer USD 17.76B 61M 2024-12
Regeneron Pharmaceuticals USD 3.79B 70M 2024-12
Roche Holding CHF 31.64B 883M 2024-12
Xencor USD 70.02M 59.31M 2024-12



MacroGenics Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.